TY - JOUR
T1 - Respiratory muscle strength and pulmonary function in unvaccinated athletes before and after COVID-19 infection
T2 - A prospective cohort study
AU - Bostancı, Özgür
AU - Karaduman, Emre
AU - Çolak, Yunus
AU - Yılmaz, Ali Kerim
AU - Kabadayı, Menderes
AU - Bilgiç, Sait
N1 - Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2023/2
Y1 - 2023/2
N2 - Purpose: We investigated abnormalities and recovery in respiratory function after COVID-19 infection in an unvaccinated elite athlete population. Methods: Measurements included maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF). Results: The most frequent reported symptoms were fatigue with 80% and muscle/joint pain and headache with 50%, whereas only 10% reported dyspnoea and 30% cough. During follow-up, MIP was up to 13% and MEP up to 8% lower following COVID-19 infection. Likewise, FEV1 was up to 2% and FVC up to 5% lower. While MEP and FEV1 rapidly normalised, MIP and FVC still remained abnormal after 52 days of COVID-19 infection, thereby leading to a restrictive ventilatory pattern. PEF seemed unaffected during follow-up. Conclusions: COVID-19 decreases respiratory function in unvaccinated athletes despite reporting few respiratory symptoms and having mild disease. An initiative aimed at reducing the long-term adverse effects following COVID-19 infection seems warranted, which perhaps may be avoided through vaccination.
AB - Purpose: We investigated abnormalities and recovery in respiratory function after COVID-19 infection in an unvaccinated elite athlete population. Methods: Measurements included maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF). Results: The most frequent reported symptoms were fatigue with 80% and muscle/joint pain and headache with 50%, whereas only 10% reported dyspnoea and 30% cough. During follow-up, MIP was up to 13% and MEP up to 8% lower following COVID-19 infection. Likewise, FEV1 was up to 2% and FVC up to 5% lower. While MEP and FEV1 rapidly normalised, MIP and FVC still remained abnormal after 52 days of COVID-19 infection, thereby leading to a restrictive ventilatory pattern. PEF seemed unaffected during follow-up. Conclusions: COVID-19 decreases respiratory function in unvaccinated athletes despite reporting few respiratory symptoms and having mild disease. An initiative aimed at reducing the long-term adverse effects following COVID-19 infection seems warranted, which perhaps may be avoided through vaccination.
KW - Athletes
KW - Forced Expiratory Volume
KW - Maximal Respiratory Pressures
KW - Respiratory Function Tests
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85141544589&partnerID=8YFLogxK
U2 - 10.1016/j.resp.2022.103983
DO - 10.1016/j.resp.2022.103983
M3 - Journal article
C2 - 36343877
AN - SCOPUS:85141544589
SN - 1569-9048
VL - 308
JO - Respiratory Physiology and Neurobiology
JF - Respiratory Physiology and Neurobiology
M1 - 103983
ER -